Abstract
Lyme disease is caused by infection with several genospecies from the Borrelia burgdorferi sensu lato (s.l.) complex, and is transmitted by ixodid ticks. Human disease is an infrequent sequel to infection, which suggests that multiple factors underlie disease development. Several innate immune defects modulating disease development are observed in both natural and experimental infections, and significant heterogeneity exists between B. burgdorferi s.l. spirochaetes. These factors create a panel of presentations from asymptomatic carriage to overt and variable disease. In this short review we summarise the host immune responses associated with Lyme disease in humans, domestic species and laboratory mouse strains, and discuss B. burgdorferi s.l. pathogenicity. We also describe briefly the epidemiology of Lyme disease, and current options for the treatment and prevention.
Similar content being viewed by others
References
Aberer E (2007) Lyme borreliosis—an update. J. Dtsch. Dermatol. Ges. 5:406–414
Alexopoulou L, Thomas V, Schnare M, Lobet Y, Anguita J, Schoen R, Medzhitov R, Fikrig E, Flavell R (2002) Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat Med 8:878–884
Antonara S, Chafel R, LaFrance M, Coburn J (2007) Borrelia burgdorferi adhesins identified using in vivo phage display. Mol Microbiol 66:262–276
Barthold S (1991) Infectivity of Borrelia burgdorferi relative to route of inoculation and genotype in laboratory mice. J Infect Dis 163:419–420
Benach JL, Coleman JL, Skinner RA, Bosler EM (1987) Adult Ixodes dammini on rabbits: a hypothesis for the development and transmission of Borrelia burgdorferi. J Infect Dis 155:1300–1306
Benoist C, Mathis D (2001) Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol 2:797–801
Bernardino A, Myers T, Alvarez X, Hasegawa A, Philipp M (2008) Toll-like receptors: insights into their possible role in the pathogenesis of lyme neuroborreliosis. Infect Immun 76:4385–4395
Blander J, Medzhitov R (2006) On regulation of phagosome maturation and antigen presentation. Nat Immunol 7:1029–1035
Blevins J, Hagman K, Norgard M (2008) Assessment of decorin-binding protein A to the infectivity of Borrelia burgdorferi in the murine models of needle and tick infection. BMC Microbiol 8:82
Brooks C, Hefty P, Jolliff S, Akins D (2003) Global analysis of Borrelia burgdorferi genes regulated by mammalian host-specific signals. Infect Immun 71:3371–3383
Brown E, Wooten R, Johnson B, Iozzo R, Smith A, Dolan M, Guo B, Weis J, Hook M (2001) Resistance to Lyme disease in decorin-deficient mice. J. Clin. Invest 107:845–852
Burgdorfer W, Barbour A, Hayes S, Benach J, Grunwaldt E, Davis J (1982) Lyme disease-a tick-borne spirochetosis? Science 216:1317–1319
Caimano M, Eggers C, Gonzalez C, Radolf J (2005) Alternate sigma factor RpoS is required for the in vivo-specific repression of Borrelia burgdorferi plasmid lp54-borne ospA and lp6.6 genes. J Bacteriol 187:7845–7852
Carroll J, Garon C, Schwan T (1999) Effects of environmental pH on membrane proteins in Borrelia burgdorferi. Infect Immun 67:3181–3187
Casjens S, Palmer N, van Vugt R, Huang W, Stevenson B, Rosa P, Lathigra R, Sutton G, Peterson J, Dodson R, Haft D, Hickey E, Gwinn M, White O, Fraser C (2000) A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol 35:490–516
Casjens S, Mongodin E, Qiu W, Luft B, Schutzer S, Gilcrease E, Huang W, Vujadinovic M, Aron J, Vargas L, Freeman S, Radune D, Weidman J, Dimitrov G, Khouri H, Sosa J, Halpin R, Dunn J, Fraser C (2012) Genome stability of Lyme disease spirochetes: comparative genomics of Borrelia burgdorferi plasmids. PLoS ONE 7:e33280
Chang Y, Ku Y, Chang C, Chang C, McDonough S, Divers T, Pough M, Torres A (2005) Antibiotic treatment of experimentally Borrelia burgdorferi-infected ponies. Vet Microbiol 107:285–294
Coleman A, Yang X, Kumar M, Zhang X, Promnares K, Shroder D, Kenedy M, Anderson J, Akins D, Pal U (2008) Borrelia burgdorferi complement regulator-acquiring surface protein 2 does not contribute to complement resistance or host infectivity. PLoS ONE 3:3010e
Doria A, Canova M, Tonon M, Zen M, Rampudda E, Bassi N, Atzeni F, Zampieri S, Ghirardello A (2008) Infections as triggers and complications of systemic lupus erythematosus. Autoimmune Rev 8:24–28
Dudai Y, Buxbaum J, Corfas G, Ofarim M (1987) Formamidines interact with Drosophila octopamine receptors, alter the flies’ behaviour and reduce their learning ability. J Comp Physiol 161:739–746
Ekerfelt C, Jarefors S, Tynngard N, Hedlund M, Sander B, Bergstrom S, Forsberg P, Ernerudh J (2003) Phenotypes indicating cytolytic properties of Borrelia-specific interferon-gamma secreting cells in chronic Lyme neuroborreliosis. J Neuroimmunol 145:115–126
Faulde M, Albiez G, Nehring O (2010) Insecticidal, acaricidal and repellent effects of DEET- and IR3535-impregnated bed nets using a novel long-lasting polymer-coating technique. Parasitol Res 106:957–965
Fischer J, Parveen N, Magoun L, Leong J (2003) Decorin-binding proteins A and B confer distinct mammalian cell type-specific attachment by Borrelia burgdorferi, the Lyme disease spirochete. Proc Natl Acad Sci USA 100:7307–7312 (Epub 2003 May 28)
Fraser C, Casjens S, Huang W, Sutton G, Clayton R, Lathigra R, White O, Ketchum K, Dodson R, Hickey E, Gwinn M, Dougherty B, Tomb J, Fleischmann R, Richardson D, Peterson J, Kerlavage A, Quackenbush J, Salzberg S, Hanson M, van Vugt R, Palmer N, Adams M, Gocayne J, Weidman J, Utterback T, Watthey L, McDonald L, Artiach P, Bowman C, Garland S, Fuji C, Cotton M, Horst K, Roberts K, Hatch B, Smith H, Venter J (1997) Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390:580–586
Gammons M, Salam G (2002) Tick removal. Am Fam Physician 66:643–645
Gautam A, Dixit S, Philipp M, Singh S, Morici L, Kaushal D, Dennis V (2011) Interleukin-10 alters effector functions of multiple genes induced by Borrelia burgdorferi in macrophages to regulate Lyme disease inflammation. Infect Immun 79:4876–4892
Hancock P, Brackley R, Palmer S (2011) Modelling the effect of temperature variation on the seasonal dynamics of Ixodes ricinus tick populations. Int J Parasitol 41:513–522
Hartmann K, Corvey C, Skerka C, Kirschfink M, Karas M, Brade V, Miller J, Stevenson B, Wallich R, Zipfel P, Kraiczy P (2006) Functional characterization of BbCRASP-2, a distinct outer membrane protein of Borrelia burgdorferi that binds host complement regulators factor H and FHL-1. Mol Microbiol 61:1220–1236
Hellwage J, Meri T, Heikkila T, Alitalo A, Panelius J, Lahdenne P, Seppala I, Meri S (2001) The complement regulator factor H binds to the surface protein OspE of Borrelia burgdorferi. J Biol Chem 276:8427–8435
Hirschfeld M, Kirschning C, Schwandner R, Wesche H, Weis J, Wooten R, Weis J (1999) Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J. Immunol 163:2382–2386
Hovius J, Levi M, Fikrig E (2008) Salivating for knowledge: potential pharmacological agents in tick saliva. PLoS Med 5:e43
Hubner A, Yang X, Nolen D, Popova T, Cabello F, Norgard M (2001) Expression of Borrelia burgdorferi OspC and DbpA is controlled by a RpoN-RpoS regulatory pathway. Proc Natl Acad Sci USA 98:12724–12729
Hunfeld K, Ruzic-Sabljic E, Norris D, Kraiczy P, Strle F (2005) In vitro susceptibility testing of Borrelia burgdorferi sensu lato isolates cultured from patients with erythema migrans before and after antimicrobial chemotherapy. Antimicrob Agents Chemother 49:1294–1301
Imai D, Barr B, Daft B, Bertone J, Feng S, Hodzic E, Johnston J, Olsen K, Barthold S (2011) Lyme neuroborreliosis in 2 horses. Vet Pathol 48:1151–1157
Jin M, Kim S, Heo J, Lee M, Kim H, Paik S, Lee H, Lee J (2007) Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide. Cell 130:1071–1082
Jones N, Germain A, Riley K, Bautista C, Taylor W, Wells A (1994) Borrelia burgdorferi decreases hyaluronan synthesis but increases IL-6 production by fibroblasts. Microb Pathog 16:261–267
Kang J, Nan X, Jin M, Youn S, Ryu Y, Mah S, Han S, Lee H, Paik S, Lee J (2009) Recognition of lipopeptide patterns by Toll-like receptor 2-Toll-like receptor 6 heterodimer. Immunity 31:873–884
Kannian P, Drouin E, Glickstein L, Kwok W, Nepom G, Steere A (2007) Decline in the frequencies of Borrelia burgdorferi OspA161 175-specific T cells after antibiotic therapy in HLA-DRB1*0401-positive patients with antibiotic-responsive or antibiotic-refractory lyme arthritis. J. Immunol 179:6336–6342
Keller A, Graefen A, Ball M, Matzas M, Boisguerin V, Maixner F, Leidinger P, Backes C, Khairat R, Forster M, Stade B, Franke A, Mayer J, Spangler J, McLaughlin S, Shah M, Lee C, Harkins T, Sartori A, Moreno-Estrada A, Henn B, Sikora M, Semino O, Chiaroni J, Rootsi S, Myres N, Cabrera V, Underhill P, Bustamante C, Vigl E, Samadelli M, Cipollini G, Haas J, Katus H, O’Connor B, Carlson M, Meder B, Blin N, Meese E, Pusch C, Zink A (2012) New insights into the Tyrolean Iceman’s origin and phenotype as inferred by whole-genome sequencing. Nat. Commun. 3:698
Kenedy MR, Lenhart TR, Akins DR (2012) The role of Borrelia burgdorferi outer surface proteins. FEMS Immunol Med Microbiol 66:1–19. doi:10.1111/j.1574-695X.2012.00980.x
Klempner M, Noring R, Epstein M, McCloud B, Hu R, Limentani S, Rogers R (1995) Binding of human plasminogen and urokinase-type plasminogen activator to the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis 171:1258–1265
Kraiczy P, Hartmann K, Hellwage J, Skerka C, Kirschfink M, Brade V, Zipfel P, Wallich R, Stevenson B (2004) Immunological characterization of the complement regulator factor H-binding CRASP and Erp proteins of Borrelia burgdorferi. Int J Med Microbiol 293:152–157
Lam T, Nguyen T, Montgomery R, Kantor F, Fikrig E, Flavell R (1994) Outer surface proteins E and F of Borrelia burgdorferi, the agent of Lyme disease. Infect Immun 62:290–298
Lawrenz M, Wooten R, Zachary J, Drouin S, Weis J, Wetsel R, Norris S (2003) Effect of complement component C3 deficiency on experimental Lyme borreliosis in mice. Infect Immun 71:4432–4440
Li X, Pal U, Ramamoorthi N, Liu X, Desrosiers D, Eggers C, Anderson J, Radolf J, Fikrig E (2007) The Lyme disease agent Borrelia burgdorferi requires BB0690, a Dps homologue, to persist within ticks. Mol Microbiol 63:694–710
Liang F, Brown E, Wang T, Iozzo R, Fikrig E (2004) Protective niche for Borrelia burgdorferi to evade humoral immunity. Am J Pathol 165:977–985
Lischer C, Leutenegger C, Braun U, Lutz H (2000) Diagnosis of Lyme disease in two cows by the detection of Borrelia burgdorferi DNA. Vet. Rec 146:497–499
Littman M, Goldstein R, Labato M, Lappin M, Moore G (2006) ACVIM small animal consensus statement on Lyme disease in dogs: diagnosis, treatment, and prevention. J Vet Intern Med 20:422–434
Ljostad U, Skogvoll E, Eikeland R, Midgard R, Skarpaas T, Berg A, Mygland A (2008) Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol 7:690–695
Lockhart E, Green A, Flynn J (2006) IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol 177:4662–4669
Magnarelli L, Ijdo J, Van Andel A, Wu C, Padula S, Fikrig E (2000) Serologic confirmation of Ehrlichia equi and Borrelia burgdorferi infections in horses from the northeastern United States. J Am Vet Med Assoc 217:1045–1050
Margos G, Vollmer S, Ogden N, Fish D (2011) Population genetics, taxonomy, phylogeny and evolution of Borrelia burgdorferi sensu lato. Infect. Genet. Evol 11:1545–1563
Martin B, Hirota K, Cua D, Stockinger B, Veldhoen M (2009) Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 31:321–330
Miller J, Ma Y, Bian J, Sheehan K, Zachary J, Weis J, Schreiber R, Weis J (2008) A critical role for type I IFN in arthritis development following Borrelia burgdorferi infection of mice. J. Immunol 181:8492–8503
Moreira L, El Kasmi K, Smith A, Finkelstein D, Fillon S, Kim Y, Nunez G, Tuomanen E, Murray P (2008) The TLR2-MyD88-NOD2-RIPK2 signalling axis regulates a balanced pro-inflammatory and IL-10-mediated anti-inflammatory cytokine response to Gram-positive cell walls. Cell Microbiol 10:2067–2077
Morgenstern K, Baljer G, Norris D, Kraiczy P, Hanssen-Hubner C, Hunfeld K (2009) In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease. Antimicrob Agents Chemother 53:1281–1284
Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I (2010) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 17:8–16
Ohnishi J, Piesman J, de Silva A (2001) Antigenic and genetic heterogeneity of Borrelia burgdorferi populations transmitted by ticks. Proc Natl Acad Sci USA 98:670–675
Omueti K, Beyer J, Johnson C, Lyle E, Tapping R (2005) Domain exchange between human toll-like receptors 1 and 6 reveals a region required for lipopeptide discrimination. J Biol Chem 280:36616–36625
Oosting M, Berende A, Sturm P, Ter Hofstede H, de Jong D, Kanneganti T, van der Meer J, Kullberg B, Netea M, Joosten L (2010) Recognition of Borrelia burgdorferi by NOD2 is central for the induction of an inflammatory reaction. J Infect Dis 201:1849–1858
Pal U, de Silva A, Montgomery R, Fish D, Anguita J, Anderson J, Lobet Y, Fikrig E (2000) Attachment of Borrelia burgdorferi within Ixodes scapularis mediated by outer surface protein A. J. Clin. Invest. 106:561–569
Pal U, Yang X, Chen M, Bockenstedt L, Anderson J, Flavell R, Norgard M, Fikrig E (2004) OspC facilitates Borrelia burgdorferi invasion of Ixodes scapularis salivary glands. J. Clin. Invest. 113:220–230
Pasare C, Medzhitov R (2004) Toll-like receptors: linking innate and adaptive immunity. Microbes Infect 6:1382–1387
Paul J, Karmakar S, De T (2012) TLR mediated distinct IFN-gamma/IL-10 pattern induces protective immunity against murine visceral leishmaniasis. Eur J Immunol 23:201242428
Petzke M, Brooks A, Krupna M, Mordue D, Schwartz I (2009) Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells. J. Immunol. 183:5279–5292
Poland G (2011) Vaccines against Lyme disease: what happened and what lessons can we learn? Clin Infect Dis 52:s253–s258
Priest H, Irby N, Schlafer D, Divers T, Wagner B, Glaser A, Chang Y, Smith M (2012) Diagnosis of Borrelia-associated uveitis in two horses. Vet Ophthalmol 23:1463–5224
Probert W, Johnson B (1998) Identification of a 47 kDa fibronectin-binding protein expressed by Borrelia burgdorferi isolate B31. Mol Microbiol 30:1003–1015
Radolf J, Caimano M, Stevenson B, Hu L (2012) Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol 10:87–99
Ramamoorthi N, Narasimhan S, Pal U, Bao F, Yang X, Fish D, Anguita J, Norgard M, Kantor F, Anderson J, Koski R, Fikrig E (2005) The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature 436:573–577
Rana A, Minz RW, Aggarwal R, Anand S, Pasricha N, Singh S (2012) Gene expression of cytokines (TNF-α, IFN-γ), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus. Lupus 21:1105–1112
Rose C, Fawcett P, Gibney K (2001) Arthritis following recombinant outer surface protein A vaccination for Lyme disease. J Rheumatol 28:2555–2557
Samuels D (2011) Gene regulation in Borrelia burgdorferi. Annu Rev Microbiol 65:479–499
Schroder N, Diterich I, Zinke A, Eckert J, Draing C, von Baehr V, Hassler D, Priem S, Hahn K, Michelsen K, Hartung T, Burmester G, Gobel U, Hermann C, Schumann R (2005) Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J. Immunol. 175:2534–2540
Schuijt T, Coumou J, Narasimhan S, Dai J, Deponte K, Wouters D, Brouwer M, Oei A, Roelofs J, van Dam A, van der Poll T, Van’t Veer C, Hovius J, Fikrig E (2011) A tick mannose-binding lectin inhibitor interferes with the vertebrate complement cascade to enhance transmission of the Lyme disease agent. Cell Host Microbe 10:136–146
Schwan T, Piesman J, Golde W, Dolan M, Rosa P (1995) Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci USA 92:2909–2913
Shaw S, Binns S, Birtles R, Day M, Smithson R, Kenny M (2005) Molecular evidence of tick-transmitted infections in dogs and cats in the United Kingdom. Vet. Rec. 157:645–648
Shi C, Sahay B, Russell J, Fortner K, Hardin N, Sellati T, Budd R (2011) Reduced immune response to Borrelia burgdorferi in the absence of gammadelta T cells. Infect Immun 79:3940–3946
Sonderegger F, Ma Y, Maylor-Hagan H, Brewster J, Huang X, Spangrude G, Zachary J, Weis J, Weis J (2012) Localized production of IL-10 suppresses early inflammatory cell infiltration and subsequent development of IFN-gamma-mediated Lyme arthritis. J. Immunol. 188:1381–1393
Stanek G, Wormser G, Gray J, Strle F (2012) Lyme borreliosis. Lancet 379:461–473
Stanneck D, Rass J, Radeloff I, Kruedewagen E, Le Sueur C, Hellmann K, Krieger K (2012) Evaluation of the long-term efficacy and safety of an imidacloprid 10 %/flumethrin 4.5 % polymer matrix collar (Seresto(R)) in dogs and cats naturally infested with fleas and/or ticks in multicentre clinical field studies in Europe. Parasit. Vectors. 5:66
Steere A, Angelis S (2006) Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis. Arthritis Rheum 54:3079–3086
Steere A, Malawista S, Snydman D, Shope R, Andiman W, Ross M, Steele F (1977) Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. Arthritis Rheum 20:7–17
Steere A, Sikand V, Meurice F, Parenti D, Fikrig E, Schoen R, Nowakowski J, Schmid C, Laukamp S, Buscarino C, Krause D (1998) Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med 339:209–215
Steere A, Klitz W, Drouin E, Falk B, Kwok W, Nepom G, Baxter-Lowe L (2006) Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide. J Exp Med 203:961–971
Stevenson B, Schwan T, Rosa P (1995) Temperature-related differential expression of antigens in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun 63:4535–4539
Straubinger R, Summers B, Chang Y, Appel M (1997) Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J Clin Microbiol 35:111–116
Straubinger R, Straubinger A, Summers B, Jacobson R, Erb H (1998) Clinical manifestations, pathogenesis, and effect of antibiotic treatment on Lyme borreliosis in dogs. Wien Klin Wochenschr 110:874–881
Strle K, Shin J, Glickstein L, Steere A (2012) Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis. Arthritis Rheum 64:1497–1507
Szczepanski A, Furie M, Benach J, Lane B, Fleit H (1990) Interaction between Borrelia burgdorferi and endothelium in vitro. J. Clin. Invest. 85:1637–1647
Taylor M (2001) Recent developments in ectoparasiticides. Vet. J. 161:253–268
Trollmo C, Meyer A, Steere A, Hafler D, Huber B (2001) Molecular mimicry in Lyme arthritis demonstrated at the single cell level: LFA-1 alpha L is a partial agonist for outer surface protein A-reactive T cells. J. Immunol. 166:5286–5291
Urban E, Chapoval A, Pauza C (2010) Repertoire development and the control of cytotoxic/effector function in human gammadelta T cells. Clin. Dev. Immunol. 2010:732893
van Burgel N, Balmus N, Fikrig E, van Dam A (2011) Infectivity of Borrelia burgdorferi sensu lato is unaltered in C3-deficient mice. Ticks Tick Borne Dis. 2:20–26
Vijverberg H, van der Zalm J, van der Bercken J (1982) Similar mode of action of pyrethroids and DDT on sodium channel gating in myelinated nerves. Nature 295:601–603
Wesch D, Peters C, Oberg H, Pietschmann K, Kabelitz D (2011) Modulation of gammadelta T cell responses by TLR ligands. Cell Mol Life Sci 68:2357–2370
Wong CK, Lit LC, Tam LS, Li EK, Wong PT, Lam CW (2008) Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin. Immunol. 127:385–393
Wooten R, Ma Y, Yoder R, Brown J, Weis J, Zachary J, Kirschning C, Weis J (2002) Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J. Immunol. 168:348–355
Wormser G, Dattwyler R, Shapiro E, Halperin J, Steere A, Klempner M, Krause P, Bakken J, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler J, Nadelman R (2006) The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43:1089–1134
Yang X, Pal U, Alani S, Fikrig E, Norgard M (2004) Essential role for OspA/B in the life cycle of the Lyme disease spirochete. J Exp Med 199:641–648
Zhang J, Norris S (1998a) Genetic variation of the Borrelia burgdorferi gene vlsE involves cassette-specific, segmental gene conversion. Infect Immun 66:3698–3704
Zhang J, Norris S (1998b) Kinetics and in vivo induction of genetic variation of vlsE in Borrelia burgdorferi. Infect Immun 66:3689–3697
Zhang J, Hardham J, Barbour A, Norris S (1997) Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes. Cell 89:275–285
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kean, I.R., Irvine, K.L. Lyme disease: aetiopathogenesis, factors for disease development and control. Inflammopharmacol 21, 101–111 (2013). https://doi.org/10.1007/s10787-012-0156-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-012-0156-2